Skip to main content

Inspire Medical Systems, Inc.

For the period ended Jun 30, 2025. Filed Aug 4, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 4, 2025

INSP$62.31-3.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Statements of Operations and Comprehensive Income (Loss)

Consolidated Statements of Operations and Comprehensive Income (Loss) (unaudited)

(in thousands, except share and per share amounts)

Three Months EndedJune 30,Six Months EndedJune 30,
2025202420252024
Revenue$217,086$195,885$418,403$359,895
Cost of goods sold34,67229,84365,38154,600
Gross profit182,414166,042353,022305,295
Operating expenses:
Research and development26,20928,85954,01257,709
Selling, general and administrative159,521132,084303,811257,705
Total operating expenses185,730160,943357,823315,414
Operating (loss) income(3,316)5,099(4,801)(10,119)
Other (income) expense:
Interest and dividend income(4,486)(5,882)(9,552)(11,805)
Interest expense4—4—
Other expense, net3,4981352,920195
Total other income(984)(5,747)(6,628)(11,610)
Income (loss) before income taxes(2,332)10,8461,8271,491
Income taxes1,2601,0532,4271,703
Net income (loss)(3,592)9,793(600)(212)
Other comprehensive income (loss):
Foreign currency translation gain (loss)191(39)(109)(173)
Unrealized loss on investments(22)(200)(31)(742)
Total comprehensive income (loss)$(3,423)$9,554$(740)$(1,127)
Net income (loss) per share:
Basic$(0.12)$0.33$(0.02)$(0.01)
Diluted$(0.12)$0.32$(0.02)$(0.01)
Weighted average shares outstanding:
Basic29,506,80729,728,84929,604,04329,672,006
Diluted29,506,80730,408,43929,604,04329,672,006
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.